FDA Update to Abortion Pill Label Aligns Care with Scientific Evidence, Improves Access to Early Abortion

2019-06-19T16:46:44-05:00March 30th, 2016|Press Releases: NIRH|

FOR IMMEDIATE RELEASE March 30, 2016 Contact: Christie Petrone, 646-520-3504, [email protected] Statement by Andrea Miller, President of the National Institute for Reproductive Health “Today’s announcement by the FDA ensures that the drug label on mifepristone will now match what medical providers and organizations have long considered the standard of care. “This change is a welcome [...]